Word

CONFO

Status

Pending

Status Code

641

Status Date

Tuesday, October 24, 2023

Serial Number

97685859

Mark Type

4000

Filing Date

Monday, November 21, 2022

Trademark Owner History

Confo Therapeutics N.V.

Classifications

5 pharmaceutical and veterinary preparations for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; chemical and biochemical substances for pharmaceutical or veterinary use screened by means of stabilized proteins, namely, small molecules and antibodies for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; veterinary products for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases

1 Laboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely, antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); Chemical substances for use in the production of drugs; Biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); Proteins for use in science; Chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs)

45 Licensing authority services; Licensing of technology; Legal administration of licences; Licensing of intellectual property; Licensing of research and development; Licensing of trademarks; Licensing of patents

42 Medical and pharmacological research services; Pharmaceutical drug development services; Laboratory research services relating to pharmaceuticals; Research and development of vaccines and medicines; Scientific research for medical purposes and the development of pharmaceutical preparations in the area of drugs interacting with G protein-coupled receptors (GPCRs); Design of computer databases; Updating of database software; Data warehousing; Provision of information and data relating to medical research and development; Rendering of computer graphics featuring digital image correction for research and development; Computer graphic design services featuring data and image processing services for making three dimensional models; Non-medical graphic design featuring digital imaging services; Optical imaging for use in research and development of medicines; Imaging via computers for use in research and development of medicines; Graphic design services for generating and processing data and images for making three dimensional models for use in research and development of medicines

The wording CONFO has no meaning in a foreign language.

Trademark Events

Jan 23, 2024

Application Extension Granted/Receipt Provided

Jan 23, 2024

Application Extension To Response Period - Received

Oct 24, 2023

Notification Of Non-Final Action E-Mailed

Oct 24, 2023

Non-Final Action E-Mailed

Oct 24, 2023

Non-Final Action Written

Sep 1, 2023

Assigned To Examiner

Dec 12, 2022

New Application Office Supplied Data Entered

Nov 24, 2022

New Application Entered